TAF15 and amyotrophic lateral sclerosis: In contrast, FUS aggregates in the CNS of ALS patients are not immunoreactive for EWS or TAF15, highlighting the distinct molecular composition of pathological FUS inclusions in ALS-FUS versus FTLD-FUS/FTLD-FET [66].